Paul Gama insider trades: PROCTER & GAMBLE (PG) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Paul reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | PG | ↓ Sell | 2,894 | $165.00 | $478K | Direct | Nov 3, 2026 (4d) |
| Oct 23, 2026 | PG | ↓ Sell | 4,331 | $161.27 | $698K | Direct | Oct 26, 2026 (3d) |
| Oct 5, 2026 | PG | ↓ Sell | 2,225 | $145.34 | $323K | Direct | Oct 6, 2026 (1d) |
| Aug 20, 2026 | PG | ↓ Sell | 3,396 | $143.79 | $488K | Direct | Aug 24, 2026 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PG insiders
Open-market trades in the last 12 months
About Paul Gama's insider trades
Paul Gama is CEO- Health Care at PROCTER & GAMBLE (PG). Since Aug 20, 2026, Paul has reported no open-market purchases and 4 sales worth $2.0M on SEC Form 4. In the last 12 months: 4 sales ($2.0M).
Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.